ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA

被引：0
|
作者：
Halpin, D. [1 ]
Bateman, E. D. [2 ]
Paggiaro, P. [3 ]
Bleecker, E. R. [4 ]
Engel, M. [5 ]
Moroni-Zentgraf, P. [5 ]
Schmidt, H. [6 ]
Kerstjens, H. A. M. [7 ]
机构：
[1] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
[2] Univ Cape Town, ZA-7925 Cape Town, South Africa
[3] Univ Pisa, Resp Pathophysiol & Rehabil Unit, Pisa, Italy
[4] Wake Forest Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC USA
[5] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Clin Applicat, Biberach, Germany
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med, Groningen, Netherlands
来源：
THORAX | 2015年 / 70卷
关键词：
D O I：
10.1136/thoraxjnl-2015-207770.285
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P148
引用
收藏
页码：A151 / A151
页数：1
相关论文
共 50 条
  • [1] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D. M. G.
    Paggiaro, P.
    Bleecker, E.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2014, 69 : A189 - A189
  • [2] Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [3] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Doherty, Dennis E.
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib Am
    RESPIROLOGY, 2015, 20 : 5 - 5
  • [4] Once-daily Tiotropium Respimat® Add-on to at Least ICS Maintenance Therapy Reduces Airflow Obstruction in Patients with Symptomatic Asthma, Independent of Allergic Status
    Murphy, Kevin R.
    Pearlman, David S.
    Dahl, Ronald
    Paggiaro, Pierluigi
    Engel, Michael
    Moroni-Zentgraf, Petra
    Luehmann, Reinhold
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB6 - AB6
  • [5] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS IN ADULT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Dusser, D.
    Buhl, R.
    Castro, M.
    Kerstjens, H. A. M.
    Paggiaro, P.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Bateman, E. D.
    THORAX, 2015, 70 : A151 - A152
  • [6] Once-daily tiotropium respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis
    Dusser, Daniel
    Buhl, Roland
    Castro, Mario
    Kerstjens, Huib
    Paggiaro, Pierluigi
    Engel, Michael
    Moroni-Zentgraf, Petra
    Unseld, Anna
    Bateman, Eric
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [7] ONCE-DAILY TIOTROPIUM RESPIMAT ADD-ON TO AT LEAST ICS IN ADULT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Frith, P.
    Dusser, D.
    Buhl, R.
    Castro, M.
    Kerstjens, H.
    Paggiaro, P.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Bateman, E.
    RESPIROLOGY, 2015, 20 : 137 - 137
  • [8] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO ICS plus LABA IMPROVES SYMPTOM CONTROL AND REDUCES EXACERBATIONS IN PATIENTS WITH SYMPTOMATIC ASTHMA
    Price, D.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Dahl, R.
    Paggiaro, P.
    Vandewalker, M.
    Kerstjens, H. A. M.
    Kaplan, A.
    THORAX, 2014, 69 : A49 - A50
  • [9] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Mansfield, L.
    Harper, T., III
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Bernstein, J. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A55 - A55
  • [10] Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy in Patients with Symptomatic Asthma: Methodology of Modeling Analyses By Serum IgE and Blood Eosinophil Levels
    Schmidt, Hendrik
    Moroni-Zentgraf, Petra
    Engel, Michael
    Dahl, Ronald
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB212 - AB212
12345